Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 701

1.

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

Turner PR, O'Connor K, Tate WP, Abraham WC.

Prog Neurobiol. 2003 May;70(1):1-32. Review.

PMID:
12927332
2.

Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts.

Gralle M, Ferreira ST.

Prog Neurobiol. 2007 May;82(1):11-32. Review.

PMID:
17428603
3.

Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Chan SL, Furukawa K, Mattson MP.

Neuromolecular Med. 2002;2(2):167-96. Review.

PMID:
12428810
4.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
5.

Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.

Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, Gouras GK, Kirkwood A, Morris RG, Shen J.

J Neurosci. 2005 Jul 20;25(29):6755-64.

6.

The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes.

Dodart JC, Mathis C, Ungerer A.

Rev Neurosci. 2000;11(2-3):75-93. Review.

PMID:
10718147
7.

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Sambamurti K, Greig NH, Lahiri DK.

Neuromolecular Med. 2002;1(1):1-31. Review.

PMID:
12025813
8.

Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport.

Bayer TA, Wirths O, Majtényi K, Hartmann T, Multhaup G, Beyreuther K, Czech C.

Brain Pathol. 2001 Jan;11(1):1-11. Review.

PMID:
11145195
9.

Beta-amyloid, neuronal death and Alzheimer's disease.

Carter J, Lippa CF.

Curr Mol Med. 2001 Dec;1(6):733-7. Review.

PMID:
11899259
10.

Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.

Marcello E, Epis R, Di Luca M.

Eur J Pharmacol. 2008 May 6;585(1):109-18. doi: 10.1016/j.ejphar.2007.11.083. Review.

PMID:
18377893
11.

Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.

Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.

Ann Neurol. 2004 Jun;55(6):801-14.

PMID:
15174014
12.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
13.

A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.

Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri DK, Greig NH.

Curr Alzheimer Res. 2006 Feb;3(1):81-90. Review.

PMID:
16472208
14.

Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.

Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M.

Mol Psychiatry. 2008 Oct;13(10):953-69.

PMID:
17726461
15.

The amyloid precursor protein of Alzheimer's disease and the Abeta peptide.

Storey E, Cappai R.

Neuropathol Appl Neurobiol. 1999 Apr;25(2):81-97. Review.

PMID:
10215996
16.

Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.

Chang KA, Suh YH.

J Pharmacol Sci. 2005 Apr;97(4):461-71. Review. Erratum in: J Pharmacol Sci. 2005 May;98(1):107.

17.

The functional neurophysiology of the amyloid precursor protein (APP) processing pathway.

Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT.

Neuropharmacology. 2010 Sep-Oct;59(4-5):243-67. doi: 10.1016/j.neuropharm.2010.02.011. Review.

PMID:
20167227
18.

Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.

Mileusnic R, Lancashire CL, Rose SP.

Ann N Y Acad Sci. 2005 Jun;1048:149-65.

PMID:
16154929
19.

Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP.

Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF.

J Neurosci. 2006 Dec 27;26(52):13428-36.

20.

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.

Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, Wang L, Herman M, Figueroa H, Yu WH, Arancio O, Duff K.

Neurobiol Dis. 2008 Jul;31(1):46-57. doi: 10.1016/j.nbd.2008.03.005.

PMID:
18504134

Supplemental Content

Support Center